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Chitosan and Crosslinked Chitosan for Colonic Specific Drug Delivery 
 
Purpose:  Chitosan has been proposed for bacterially triggered targeted drug release to 
the coloncolon;, however, its degradation by human colonic microflora has never 
been shown; it has been suggested that these bacteria may not be capable of chitosan 
digestion.  The purpose of this study is to establish this fact, and investigate further 
factors pertinent to colonic drug delivery; pancreatic digestion and swelling of 
chitosan in aqueous conditions.  Furthermore, we examine the effects of crosslinking 
on chitosan.     
 
Methods:  Chitosan films were prepared by dissolution of chitosan into 5% acetic acid 
in water, and casting onto Teflon plates, with/ without the addition of crosslinking 
agents.  The films were incubated in 10% human faecal material (in pH 6.8 phosphate 
buffered saline [PBS]), pancreatic enzymes (porcine, USP, in PBS pH 6.8) or control 
conditions (PBS pH 6.8), under anaerobic conditions, at 37
o
C for 4 or 18 hours.  The 
extent of digestion was assessed by measuring the weight loss.   Swelling of the films 
was assessed over a 24 hour period, by incubation in phosphate buffered saline (pH 
6.8) or hydrochloric acid (0.1N, pH 1.2), with weighing at intervals to establish water 
uptake.   
 
Results 
 
Chitosan (uncrosslinked) showed complete digestion by human faecal bacteria.  
Crosslinking chitosan with tripolyphosphate did not reduce the amount of digestion, 
but crosslinking with glutaraldehyde was able to significantly inhibit digestion at 4 
hours.  When developed as a dosage form, these materials must avoid degradation in 
the upper gastrointestinal tract by dissolution or pancreatic enzymatic digestion.  
Chitosan (uncrosslinked) showed acid dissolution, high swelling at pH 6.8 and was 
digested by pancreatic enzymes.  Chitosan crosslinked with tripolyphosphate showed 
less water uptake, and at high crosslinker concentrations acid dissolution was 
prevented.  Pancreatic enzymatic digestion was also avoided at 4 hours.  
Glutaraldehyde crosslinked chitosan had very low swelling and avoided pancreatic 
digestion.    
.  Uncrosslinked Chitosan wais completelyed digested by human faecal microflora 
and pancreatic enzymes in 4 hours.  Covalent crosslinking (glutaraldehyde) inhibited 
colonic and pancreatic digestion at 4 hours.  Ionic crosslinking (tripolyphosphate) 
inhibited pancreatic, digestion, but not faecal,  full digestion in faecal material was 
seen at 4 hours.  The resistance to digestion by crosslinked chitosan is cross-linker 
concentration dependent, and related to the polymeric network density.  This can be 
seen with concentration and crosslinker dependent swelling; noncrosslinked chitosan 
swells the most at pH 6.8 and dissolves at pH 1.2.   Glutaraldehyde crosslinked 
chitosan shows least swelling at either pH, and no acid dissolution.  Tripolyphosphate 
crosslinked chitosan falls between these.   
 
 
Conclusion.  Colonic microflora bacteria are capable of digesting chitosan.  However, 
chitosan alone, or chitosan crosslinked with glutaraldehyde do not show appropriate 
digestion/ swelling profiles necessary for colon specific release.  Chitosan, 
crosslinked with tripolyphosphate may show some potential as a colonic drug carrier; 
further investigation is warranted.   
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